Analysis of Using Low Dose 3 Factor PCC (Bebulin®) for INR Reversal in Patients with Warfarin Induced Severe/Life-Threatening Bleeding
Year: 2014
Type: article
Study design: Observational Study
Source: Blood
Institutions: Northwell Health, North Shore University Hospital
Language: English
Subfield: Biochemistry
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W985686745
